GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Quick Ratio

Hemagen Diagnostics (Hemagen Diagnostics) Quick Ratio : 0.38 (As of Sep. 2012)


View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Hemagen Diagnostics's quick ratio for the quarter that ended in Sep. 2012 was 0.38.

Hemagen Diagnostics has a quick ratio of 0.38. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Hemagen Diagnostics's Quick Ratio or its related term are showing as below:

HMGN's Quick Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.59
* Ranked among companies with meaningful Quick Ratio only.

Hemagen Diagnostics Quick Ratio Historical Data

The historical data trend for Hemagen Diagnostics's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Quick Ratio Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.77 1.18 0.65 0.38

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.36 0.44 0.41 0.38

Competitive Comparison of Hemagen Diagnostics's Quick Ratio

For the Biotechnology subindustry, Hemagen Diagnostics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemagen Diagnostics's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's Quick Ratio falls into.



Hemagen Diagnostics Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Hemagen Diagnostics's Quick Ratio for the fiscal year that ended in Sep. 2012 is calculated as

Quick Ratio (A: Sep. 2012 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(2.095-1.363)/1.95
=0.38

Hemagen Diagnostics's Quick Ratio for the quarter that ended in Sep. 2012 is calculated as

Quick Ratio (Q: Sep. 2012 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(2.095-1.363)/1.95
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hemagen Diagnostics  (OTCPK:HMGN) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Hemagen Diagnostics Quick Ratio Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.
Executives
Howard F Curd director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines